Modrowski D - Search Results

1

Syndecan-2 overexpression induces osteosarcoma cell apoptosis: Implication of syndecan-2 cytoplasmic domain and JNK signaling.

Modrowski D, Orosco A, Thévenard J, Fromigué O, Marie PJ. Modrowski D, et al. Bone. 2005 Aug;37(2):180-9. doi: 10.1016/j.bone.2005.04.010. Bone. 2005. PMID: 15936998

2

Apoptosis in membranous bone formation: role of fibroblast growth factor and bone morphogenetic protein signaling.

Fromigue O, Modrowski D, Marie PJ. Fromigue O, et al. Among authors: modrowski d. Crit Rev Eukaryot Gene Expr. 2005;15(1):75-92. doi: 10.1615/critreveukaryotgeneexpr.v15.i1.50. Crit Rev Eukaryot Gene Expr. 2005. PMID: 15831079 Review.

3

Dual involvement of protein kinase C delta in apoptosis induced by syndecan-2 in osteoblasts.

Orosco A, Fromigué O, Haÿ E, Marie PJ, Modrowski D. Orosco A, et al. Among authors: modrowski d. J Cell Biochem. 2006 Jul 1;98(4):838-50. doi: 10.1002/jcb.20826. J Cell Biochem. 2006. PMID: 16440330

4

Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma.

Orosco A, Fromigué O, Bazille C, Entz-Werle N, Levillain P, Marie PJ, Modrowski D. Orosco A, et al. Among authors: modrowski d. Cancer Res. 2007 Apr 15;67(8):3708-15. doi: 10.1158/0008-5472.CAN-06-4164. Cancer Res. 2007. PMID: 17440083

5

High Wnt signaling represses the proapoptotic proteoglycan syndecan-2 in osteosarcoma cells.

Dieudonné FX, Marion A, Haÿ E, Marie PJ, Modrowski D. Dieudonné FX, et al. Among authors: modrowski d. Cancer Res. 2010 Jul 1;70(13):5399-408. doi: 10.1158/0008-5472.CAN-10-0090. Epub 2010 Jun 8. Cancer Res. 2010. PMID: 20530678

6

Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitization to doxorubicin in osteosarcoma cells and bone tumors in mice.

Dieudonné FX, Marion A, Marie PJ, Modrowski D. Dieudonné FX, et al. Among authors: modrowski d. J Bone Miner Res. 2012 Oct;27(10):2118-29. doi: 10.1002/jbmr.1650. J Bone Miner Res. 2012. PMID: 22550000 Free article.

7

Targeting the E3 ubiquitin casitas B-lineage lymphoma decreases osteosarcoma cell growth and survival and reduces tumorigenesis.

Sévère N, Dieudonné FX, Marty C, Modrowski D, Patiño-García A, Lecanda F, Fromigué O, Marie PJ. Sévère N, et al. Among authors: modrowski d. J Bone Miner Res. 2012 Oct;27(10):2108-17. doi: 10.1002/jbmr.1667. J Bone Miner Res. 2012. PMID: 22623369 Free article.

8

Differential expression of fibroblast growth factor receptor-1, -2, and -3 and syndecan-1, -2, and -4 in neonatal rat mandibular condyle and calvaria during osteogenic differentiation in vitro.

Molténi A, Modrowski D, Hott M, Marie PJ. Molténi A, et al. Among authors: modrowski d. Bone. 1999 Apr;24(4):337-47. doi: 10.1016/s8756-3282(98)00191-4. Bone. 1999. PMID: 10221546

9

Syndecan-2 is involved in the mitogenic activity and signaling of granulocyte-macrophage colony-stimulating factor in osteoblasts.

Modrowski D, Baslé M, Lomri A, Marie PJ. Modrowski D, et al. J Biol Chem. 2000 Mar 31;275(13):9178-85. doi: 10.1074/jbc.275.13.9178. J Biol Chem. 2000. PMID: 10734053 Free article.

10

RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation.

Fromigué O, Haÿ E, Modrowski D, Bouvet S, Jacquel A, Auberger P, Marie PJ. Fromigué O, et al. Among authors: modrowski d. Cell Death Differ. 2006 Nov;13(11):1845-56. doi: 10.1038/sj.cdd.4401873. Epub 2006 Feb 10. Cell Death Differ. 2006. PMID: 16470222

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters